New EORTC guidelines establish meaningful change thresholds for symptom burden, physical condition/fatigue, and worries/fears in R/R CLL or SLL patients. Thresholds help identify significant ...
The CLLAF Score predicts AF risk in CLL patients on BTKi therapy, including second-generation BTKis, using easily obtainable parameters. Ibrutinib is associated with a higher AF risk compared to ...
Which Is the Best Tyrosine Kinase Inhibitor for Newly Diagnosed Chronic Myelogenous Leukemia? Chronic lymphocytic leukemia (CLL) remains an incurable disease, except in rare cases treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results